Literature DB >> 17177290

The role of the organ microenvironment in the biology and therapy of cancer metastasis.

Isaiah J Fidler1, Sun-Jin Kim, Robert R Langley.   

Abstract

By the time of diagnosis, primary neoplasms are biologically heterogeneous and contain subpopulations of cells with different metastatic potentials. The pathogenesis of a metastasis consists of many sequential steps that must be completed to produce clinically relevant lesions. During any of these steps, tumor cells interact with host factors in the microenvironment that the tumor cells can usurp. Treatment of metastasis can be directed against tumor cells and/or microenvironmental factors that support tumor growth, such as tumor-associated blood vessels.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17177290     DOI: 10.1002/jcb.21148

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  47 in total

1.  Histochemical analyses and quantum dot imaging of microvascular blood flow with pulmonary edema in living mouse lungs by "in vivo cryotechnique".

Authors:  Yurika Saitoh; Nobuo Terada; Sei Saitoh; Nobuhiko Ohno; Takashi Jin; Shinichi Ohno
Journal:  Histochem Cell Biol       Date:  2011-11-29       Impact factor: 4.304

2.  Induction of lung epithelial cell transformation and fibroblast activation by Yunnan tin mine dust and their interaction.

Authors:  Li Bian; Yong-Wen He; Rui-Zhu Tang; Li-Ju Ma; Chun-Yan Wang; Yong-Hua Ruan; Qian Gao; Ke-Wei Jin
Journal:  Med Oncol       Date:  2010-08-18       Impact factor: 3.064

Review 3.  Crosstalk between cancer cells and blood endothelial and lymphatic endothelial cells in tumour and organ microenvironment.

Authors:  Esak Lee; Niranjan B Pandey; Aleksander S Popel
Journal:  Expert Rev Mol Med       Date:  2015-01-30       Impact factor: 5.600

4.  Cyclooxygenase-2 expression in primary breast cancers predicts dissemination of cancer cells to the bone marrow.

Authors:  Anthony Lucci; Savitri Krishnamurthy; Balraj Singh; Isabelle Bedrosian; Funda Meric-Bernstam; James Reuben; Kristine Broglio; Kailash Mosalpuria; Ashutosh Lodhi; Laura Vincent; Massimo Cristofanilli
Journal:  Breast Cancer Res Treat       Date:  2008-07-29       Impact factor: 4.872

5.  A multi-site metastasis-on-a-chip microphysiological system for assessing metastatic preference of cancer cells.

Authors:  Julio Aleman; Aleksander Skardal
Journal:  Biotechnol Bioeng       Date:  2018-12-31       Impact factor: 4.530

6.  Intratumoral heterogeneity for expression of tyrosine kinase growth factor receptors in human colon cancer surgical specimens and orthotopic tumors.

Authors:  Toshio Kuwai; Toru Nakamura; Sun-Jin Kim; Takamitsu Sasaki; Yasuhiko Kitadai; Robert R Langley; Dominic Fan; Stanley R Hamilton; Isaiah J Fidler
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

7.  Anti-metastatic effects of liposomal gemcitabine in a human orthotopic LNCaP prostate cancer xenograft model.

Authors:  Peter Jantscheff; Vittorio Ziroli; Norbert Esser; Ralph Graeser; Jessica Kluth; Alena Sukolinskaya; Lenka A Taylor; Clemens Unger; Ulrich Massing
Journal:  Clin Exp Metastasis       Date:  2009-09-26       Impact factor: 5.150

Review 8.  Perspectives on the mesenchymal origin of metastatic cancer.

Authors:  Leanne C Huysentruyt; Thomas N Seyfried
Journal:  Cancer Metastasis Rev       Date:  2010-12       Impact factor: 9.264

9.  Role of the gp85/trans-sialidases in Trypanosoma cruzi tissue tropism: preferential binding of a conserved peptide motif to the vasculature in vivo.

Authors:  Renata R Tonelli; Ricardo J Giordano; Elena Magda Barbu; Ana Claudia Torrecilhas; Gerson S Kobayashi; Robert R Langley; Wadih Arap; Renata Pasqualini; Walter Colli; Maria Júlia M Alves
Journal:  PLoS Negl Trop Dis       Date:  2010-11-02

10.  GRP78 and GAL3, differentially regulated by lymph node homogenates, as potential biomarkers for lymph node metastasis in mouse hepatocellular carcinoma cells.

Authors:  Wenjun Zhu; Lawrence Owusu; Shizhu Zang; Yunjuan Zhang; Yi Xin; Chao Yan
Journal:  Oncol Lett       Date:  2012-09-13       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.